Edge Therapeutics

A biotechnology company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions.

Launch date

2009

Employees

Market cap

Enterprise valuation

Berkeley Heights New Jersey (HQ)

Revenues, earnings & profits over time

EUR	2017
R&D budget	29.0m

Source: Dealroom estimates

Date	Investors	Amount	Round
May 2010	N/A	N/A	Seed
Nov 2010	N/A	$630k	Series A
Jun 2011	N/A	$220k	Seed
Sep 2012	N/A	$120k	Seed
Jun 2013	Venrock New Leaf Venture Partners Janus Capital Group BioMed Ventures Sofinnova Ventures Franklin Advisors	$18.0m	Series C
Sep 2014	N/A	$10.0m	Debt
Dec 2014	Venrock New Leaf Venture Partners Janus Capital Group BioMed Ventures Sofinnova Ventures Franklin Advisors	$16.5m	Series C
Apr 2015	Venrock New Leaf Venture Partners Janus Capital Group BioMed Ventures Sofinnova Ventures Franklin Advisors	$56.0m	Series C
Sep 2015	N/A	N/A	IPO
Nov 2018	PDS Biotechnology Corporation	N/A	Merger
Total Funding		CAD125m

Tech stackLearn more about the technologies and tools that this company uses.

Financials